《肝细胞癌中ROS相关基因在预后、免疫浸润和药物敏感性方面的系统分析》勘误
Corrigendum to "System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma".
作者信息
Xu Jun Hui, Guan Yong Jun, Qiu Zhen Dong, Zhang Xin, Zi Liu Liu, Zhou Yu, Chen Chen, Yu Jia, Zhang Yi Chao, Wang Wei Xing
机构信息
Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
出版信息
Oxid Med Cell Longev. 2022 Feb 21;2022:9875295. doi: 10.1155/2022/9875295. eCollection 2022.
Abstract
[This corrects the article DOI: 10.1155/2021/6485871.].
摘要
[本文更正了文章的数字对象标识符：10.1155/2021/6485871。]
相似文献
1
Corrigendum to "System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma".《肝细胞癌中ROS相关基因在预后、免疫浸润和药物敏感性方面的系统分析》勘误
Oxid Med Cell Longev. 2022 Feb 21;2022:9875295. doi: 10.1155/2022/9875295. eCollection 2022.
2
System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma.ROS 相关基因在肝细胞癌预后、免疫浸润和药物敏感性中的系统分析。
Oxid Med Cell Longev. 2021 Nov 8;2021:6485871. doi: 10.1155/2021/6485871. eCollection 2021.
3
Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma.勘误：ASPM是一种预后生物标志物，与肾透明细胞癌和肝细胞癌中的免疫浸润相关。
Front Oncol. 2022 Aug 22;12:979968. doi: 10.3389/fonc.2022.979968. eCollection 2022.
4
Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.勘误：CDT1是一种用于肝细胞癌的新型预后和预测生物标志物。
Front Oncol. 2021 Nov 9;11:801970. doi: 10.3389/fonc.2021.801970. eCollection 2021.
5
Corrigendum: Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis.勘误：通过微阵列数据和免疫浸润分析探索肝炎病毒诱导肝细胞癌的分子机制。
Front Immunol. 2023 Feb 28;14:1168774. doi: 10.3389/fimmu.2023.1168774. eCollection 2023.
6
Corrigendum: A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.勘误：泛癌中肌动蛋白相关蛋白2/3复合体亚基5的综合预后和免疫分析及在肝细胞癌中的鉴定
Front Immunol. 2022 Oct 17;13:1047151. doi: 10.3389/fimmu.2022.1047151. eCollection 2022.
7
Corrigendum: CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis.勘误：CCDC25可能是肝细胞癌的潜在诊断和预后标志物：来自微阵列分析的结果。
Front Surg. 2023 Mar 28;10:1175721. doi: 10.3389/fsurg.2023.1175721. eCollection 2023.
8
Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.勘误：肝细胞癌诊断和预后新型生物标志物的鉴定与验证。
Front Oncol. 2020 Nov 20;10:617539. doi: 10.3389/fonc.2020.617539. eCollection 2020.
9
Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.勘误：上调的LINC01667表达与肝细胞癌的不良预后相关。
Front Oncol. 2021 Oct 15;11:785394. doi: 10.3389/fonc.2021.785394. eCollection 2021.
10
Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.勘误：与原发性胆汁酸生物合成及肝细胞癌肿瘤微环境相关的线粒体相关预后生物标志物的鉴定。
Front Oncol. 2022 Jan 17;11:843623. doi: 10.3389/fonc.2021.843623. eCollection 2021.
本文引用的文献
1
System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma.ROS 相关基因在肝细胞癌预后、免疫浸润和药物敏感性中的系统分析。
Oxid Med Cell Longev. 2021 Nov 8;2021:6485871. doi: 10.1155/2021/6485871. eCollection 2021.
Zotero 插件